Virtual Medicinal Product (VMP)
-
Generic Spikevax COVID-19 mRNA (nucleoside modified) Vaccine 0.1mg/0.5ml dose dispersion for injection multidose vials
Name Details
Current Name
Generic Spikevax COVID-19 mRNA (nucleoside modified) Vaccine 0.1mg/0.5ml dose dispersion for injection multidose vials
|
Start Date
15-09-2021
|
End Date
|
Previous Name
Generic COVID-19 mRNA (nucleoside modified) Vaccine Moderna 0.1mg/0.5ml dose dispersion for injection multidose vials
|
Start Date
18-03-2021
|
End Date
14-09-2021
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 0.5
- UDFS UOM
- ml
- Unit Dose UOM
- dose
Summary
- Prescribing Status
- Never Valid To Prescribe As A VMP
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intramuscular
- Form
- Dispersion for injection
- Ontology Form/Route
- dispersioninjection.intramuscular
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- Other
Codes
- ATC Code
-
n/a
BNF |
Current BNF
14040000
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
14040000
|
Start Date
12-01-2021
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
39326811000001106 |
12-01-2021 |
|
Virtual Medicinal Product Pack (VMPP) Information